Study Cites High Cancer Rates Among African-Americans

Publication
Article
OncologyONCOLOGY Vol 20 No 11
Volume 20
Issue 11

Astudy conducted by researchers from the Medical University of South Carolina (MUSC) and University of South Carolina shows that the cancer rate among blacks living in South Carolina is nearly twice as great as it is for whites in the state.

Astudy conducted by researchers from the Medical University of South Carolina (MUSC) and University of South Carolina shows that the cancer rate among blacks living in South Carolina is nearly twice as great as it is for whites in the state. The study, released September 13 by the Journal of the South Carolina Medical Association, focuses on racial imbalances that exist in African-American and European-American cancer rates in South Carolina, while comparing cancer disparities between the two races nationally.

Key Findings

South Carolina leads the nation in cancer rates. The study found that in South Carolina:

• African-American women are about 60% more likely than white women to die from breast cancer after diagnosis, which is the largest disparity in the country.

• African-American men are nearly 80% more likely to get prostate cancer and nearly three times more likely to die of the disease than white men. This is about 50% of the rate nationally.

• Both African-American men and women are more likely to have and die of colorectal cancer than their white counterparts.

• African-American women are much more likely to be diagnosed and die from cervical cancer; despite similar screening rates.

Innovative Programs

MUSC's Anthony Alberg, PhD, associate director and chairman of Cancer Prevention and Control at MUSC's Hollings Cancer Center, the largest academic-based cancer program in South Carolina, also was an author of the study. His focus has been on the causes of lung cancer among African-Americans.

"We understand the importance of the issue of cancer disparities, and we are creating innovative programs to help educate African-Americans on the importance of early tests, and how lifestyle choices, including not smoking, eating a healthy diet, and exercise can help to prevent many cancers," said Dr. Alberg.

Meanwhile, programs including Health-e-AME and Brothers Against Prostate Cancer, which is operated through barber shops in South Carolina, are supported by MUSC and focus on cancer prevention and other health disparities among African-Americans.

Although some of the differences are clearly related to socioeconomic factors that determine access to health care, "we are pretty much in the dark regarding many of the underlying causes," said James Hebert, PhD, a University of South Carolina researcher and a journal contributor.

Recent Videos
Breast cancer care providers make it a goal to manage the adverse effects that patients with breast cancer experience to minimize the burden of treatment.
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
Thinking about how to sequence additional agents following targeted therapy may be a key consideration in the future of lung cancer care.
Endobronchial ultrasound, robotic bronchoscopy, or other expensive procedures may exacerbate financial toxicity for patients seeking lung cancer care.
Patients with mediastinal lymph node involved-lung cancer may benefit from chemoimmunotherapy in the neoadjuvant setting.
Advancements in antibody drug conjugates, bispecific therapies, and other targeted agents may hold promise in lung cancer management.
Stressing the importance of prompt AE disclosure before they become severe can ensure that a patient can still undergo resection with curative intent.
Thomas Marron, MD, PhD, presented a session on clinical data that established standards of care for stage II and III lung cancer treatment at CFS 2025.
Antibody-drug conjugates are effective, but strategies such as better understanding the mechanisms of action may lead to enhanced care for patients with cancer. Antibody-drug conjugates are effective, but strategies such as better understanding the mechanisms of action may lead to enhanced care for patients with cancer.
Related Content